Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of High Dose Inhaled Corticosteroids as Treatment of Early COVID-19 Infection to Prevent Clinical Deterioration and Hospitalisation

NCT04416399 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT04416399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04416399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of High Dose Inhaled Corticosteroids as Treatment of Early COVID-19 Infection to Prevent Clinical Deterioration and Hospitalisation
Lead sponsor
University of Oxford
Phase
Phase 2
Overall status
Terminated
Start date
July 16, 2020
Completion date
January 12, 2021
Enrollment
146 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection